191 related articles for article (PubMed ID: 30834826)
1. Molecular Basis of Modulating Adenosine Receptors Activities.
Mahmod Al-Qattan MN; Mordi MN
Curr Pharm Des; 2019; 25(7):817-831. PubMed ID: 30834826
[TBL] [Abstract][Full Text] [Related]
2. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors.
Salmaso V; Jacobson KA
Biomolecules; 2020 May; 10(6):. PubMed ID: 32466404
[TBL] [Abstract][Full Text] [Related]
3. Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends.
Al-Shar'i NA; Al-Balas QA
Curr Pharm Des; 2019; 25(7):783-816. PubMed ID: 30834825
[TBL] [Abstract][Full Text] [Related]
4. Allosteric modulation of G protein-coupled receptors.
May LT; Leach K; Sexton PM; Christopoulos A
Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
[TBL] [Abstract][Full Text] [Related]
5. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
6. The role of receptor structure in determining adenosine receptor activity.
Olah ME; Stiles GL
Pharmacol Ther; 2000 Feb; 85(2):55-75. PubMed ID: 10722120
[TBL] [Abstract][Full Text] [Related]
7. Rational design of dualsteric GPCR ligands: quests and promise.
Mohr K; Tränkle C; Kostenis E; Barocelli E; De Amici M; Holzgrabe U
Br J Pharmacol; 2010 Mar; 159(5):997-1008. PubMed ID: 20136835
[TBL] [Abstract][Full Text] [Related]
8. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of adenosine receptors.
Göblyös A; Ijzerman AP
Biochim Biophys Acta; 2011 May; 1808(5):1309-18. PubMed ID: 20599682
[TBL] [Abstract][Full Text] [Related]
10. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
11. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.
Vincenzi F; Pasquini S; Borea PA; Varani K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218074
[TBL] [Abstract][Full Text] [Related]
12. Allosteric Modulators of the Class A G Protein Coupled Receptors.
Tschammer N
Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Rational Design of Adenosine Receptor Ligands.
Gutiérrez-de-Terán H; Sallander J; Sotelo E
Curr Top Med Chem; 2017; 17(1):40-58. PubMed ID: 27448653
[TBL] [Abstract][Full Text] [Related]
14. Allosteric modulators for adenosine receptors: an alternative to the orthosteric ligands.
La Motta C; Sartini S; Morelli M; Taliani S; Da Settimo F
Curr Top Med Chem; 2010; 10(10):976-92. PubMed ID: 20370657
[TBL] [Abstract][Full Text] [Related]
15. Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist.
Valant C; May LT; Aurelio L; Chuo CH; White PJ; Baltos JA; Sexton PM; Scammells PJ; Christopoulos A
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4614-9. PubMed ID: 24619092
[TBL] [Abstract][Full Text] [Related]
16. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
Feng Z; Hu G; Ma S; Xie XQ
AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
[TBL] [Abstract][Full Text] [Related]
17. Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications.
Pasquini S; Contri C; Cappello M; Borea PA; Varani K; Vincenzi F
Front Pharmacol; 2022; 13():1030895. PubMed ID: 36278183
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
Reinecke BA; Wang H; Zhang Y
Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
[TBL] [Abstract][Full Text] [Related]
19. Molecular Simulations and Drug Discovery of Adenosine Receptors.
Wang J; Bhattarai A; Do HN; Akhter S; Miao Y
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408454
[TBL] [Abstract][Full Text] [Related]
20. Allosteric properties of G protein-coupled receptor oligomers.
Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
